The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of thymosin alpha-1 (TA1) are reviewed. Clinical trials of TA1 for chronic hepatitis B or C ...

ASADA is alleging the 34 players and one support person, no longer employed by Essendon, breached the AFL Anti-Doping Code through the use of the banned peptide thymosin beta-4. In December, ASADA ...

Andreone and colleagues [8] conducted a randomized, multicenter trial of TA1 versus IFN- 2b. Criteria for inclusion were age 18 to 60 years, HBsAg in the serum for at least a year, positive serum ...